Abstract: Methods of ameliorating, treating, or reducing post-dialysis washout or hangover comprising administering, near the end of or subsequent to a dialysis session, one or more or a group of amino acids and/or their hydroxy or keto analogs. The group of amino acids may be one or more members selected from the group consisting of histidine, alanine, isoleucine, arginine, leucine, asparagine, lysine, aspartic acid, methionine, cysteine, phenylalanine, glutamic acid, threonine, glutamine, tryptophan, glycine, valine, pyrrolysine, proline, selenocysteine, serine, and tyrosine, or their keto or hydroxy analogs and mixtures thereof.

Abstract: Methods of ameliorating, treating, or reducing post-dialysis washout or hangover comprising administering, near the end of or subsequent to a dialysis session, one or more or a group of amino acids and/or their hydroxy or keto analogs. The group of amino acids may be one or more members selected from the group consisting of histidine, alanine, isoleucine, arginine, leucine, asparagine, lysine, aspartic acid, methionine, cysteine, phenylalanine, glutamic acid, threonine, glutamine, tryptophan, glycine, valine, pyrrolysine, proline, selenocysteine, serine, and tyrosine, or their keto or hydroxy analogs and mixtures thereof.

Abstract: The present invention discloses compositions and methods for ameliorating or reducing recurrent viral disease, which compositions and methods result in an increase in virus specific immunoglobulin subclasses reflective of a preferential Th1 response.

Abstract: This invention concerns stabilized virus compositions, preferably a herpesvirus which may be an attenuated or genetically modified herpes simplex virus or varicella zoster virus, and a method of stabilizing viruses and immunizing preparations by the addition of sugars, preferably glucose and amino acids, preferably lysine.

Abstract: Methods are disclosed for the preparation of herpesvirus, such as herpes simplex virus type 2 for vaccine use. Such viruses can be grown on serum free or serum containing media and can be prepared from the virus containing culture supernatant or virus containing cells. The virus is prepared for subsequent pharmaceutical formulation by methods which may include treatment with solid phase affinity reagents containing sulfate- or sulfonate-comprising binding groups. Such sulfated polysaccharide groups as heparin or dextran sulfate may be used, and eluted with salt solutions. The process can be combined with other culture, harvesting and formulation steps.

Abstract: Methods and compositions for treating gastric reflux or the pain associated therewith comprising orally administering therapeutically effective amounts of a compound or composition capable of releasing nitric oxide in a pharmaceutically acceptable composition are described herein.

Abstract: Nutrient formulations are provided having a high content of carrageenan and a low liquid content. The nutrient formulation also contains at least one nutritional and/or pharmaceutical component such as flavorings, sweeteners, amino acids, fruit solids, protein and carbohydrates. The formulations are produced by mixing at least one carrageenan at a minimum of 5% by weight, and the desired nutritional and/or pharmaceutical component with no more than 50% by weight of a liquid.

Abstract: The present invention discloses compositions and methods for ameliorating or reducing recurrent viral disease, which compositions and methods result in an increase in virus specific immunoglobulin subclasses reflective of a preferential Th1 response.

Abstract: A method of inhibiting an undesirable taste in oral compositions such as foods, beverages, and pharmaceuticals is disclosed. Also disclosed are oral and pharmaceutical compositions comprising undesirable tasting compounds wherein said undesirable tastes are inhibited by the addition of at least one sulfated polysaccharide to the oral and pharmaceutical compositions. Preferred sulfated polysaccharides include carrageenan compounds or a mixture thereof.

Abstract: Nutrient formulations are provided having a high content of carrageenan and a low liquid content. The nutrient formulation also contains at least one nutritional and/or pharmaceutical component such as flavorings, sweeteners, amino acids, fruit solids, protein and carbohydrates. The formulations are produced by mixing at least one carrageenan at a minimum of 5% by weight, and the desired nutritional and/or pharmaceutical component with no more than 50% by weight of a liquid.

Abstract: Masking compositions are provided comprising at least one unpleasant tasting amino acid other than arginine, protein hydrolysate and/or protein component wherein the taste of the unpleasant tasting component is masked with the addition of sucralose to provide organoleptically acceptable compositions. Masking compositions in accordance with the invention may then be incorporated in beverages, foods, bars, or candies to provide nutrient products.

Abstract: A method of inhibiting an undesirable taste in oral compositions such as foods, beverages, and pharmaceuticals is disclosed. Also disclosed are oral and pharmaceutical compositions comprising undesirable tasting compounds wherein said undesirable tastes are inhibited by the addition of at least one sulfated polysaccharide to the oral and pharmaceutical compositions. Preferred sulfated polysaccharides include carrageenan compounds or a mixture thereof.

Abstract: Synergistic mixtures of a zeolite and an imide provide superior relief from objectionable odors. The compostions are especially effective to remove the odor of animal wastes or fluids. The mixture may be sprinkled on dogs, dog bedding, horse stalls, animal vomit, urine deposits, fish remains, fish juices and the like. The zeolite/imide mixture will also remove odors from carpets, clothes, hands or other body parts, cloth and plastic items.

Abstract: This invention discloses slow release formulations for use in application of volatile insect repellents. A copolymer of polyvinyl pyrrolidone and an alkyl group of 4-30 carbons provides the slow release properties. The formulations are characterized by high residual action, low skin penetration, and high resistance to removal by water.

Abstract: A dry zeolite containing composition is used in a method for removing grease and/or oil stains from the human body is disclosed. In accordance with the method, zeolites having an average particle size of about 0.5 mm or less provide superior performance to remove grease and oil stains from the skin. Stain removing activities of the zeolite compositions may be enhanced by the addition of an imide.

Abstract: An improved method for the removal of stains from textiles is disclosed. The method involves the use of novel mixtures of zeolites and imides. The method of the invention provides superior performance in the removal of stains, especially those from animal wastes or fluids. The zeolite/imide mixtures are useful to remove stains from various textile fabrics and fibers, e.g. carpets, clothing, and upholstered goods.

Abstract: Copolymers of polyaspartic acid which are suitable for the inhibition of scale deposition were obtained by reacting maleic acid, an additional polycarboxylic acid and ammonia in a stoichiometric excess, at 120.degree.-350.degree. C., preferably 180.degree.-300.degree. C., to provide copolymers of polysuccinimide. In a second embodiment, a polyamine was added to the reaction mix. These intermediate polysuccinimide copolymers could then be converted to the salts of copolymers of polyaspartic acid by hydrolysis with a hydroxide. Such copolymers are useful in preventing deposition of scale from water and find applications in treating water. Other applications include scale prevention additives for detergents. In addition, such copolymers inhibit dental tartar and plaque formation.

Abstract: The present method relates to the serological detection of herpes simplex virus type 2 (HSV-2) infection by means of reaction of a patient serum with a peptide specific to HSV-2 having the sequence Ala-Arg-Ser-Pro-Glu -Arg-Gln-Glu-Pro-Arg-Glu-Pro-Glu. The peptide may be further modified by the addition of a Cys or a biotin molecule. The peptide may be used in any of a number of assays including enzyme linked immunosorbent assay (ELISA), a radioimmunoassay (RIA), and other forms of immunoassay such as enzyme immunoblotting assay on a suitable adsorbent paper or an agglutination assay using the peptide composition as the antigen.

Abstract: Imides reduce odors. Imides are especially efficient at reducing the odors of odoriferous an amine or ammonia. The imides may be incorporated in pads which are the recipients of odoriferous waste materials, dispersed in holding tanks or lagoons or dispersed over human and animal wastes. Polysuccinimide, copolymers of polysuccinimide, polyglutarimide and mixtures thereof are especially useful for the reduction of odors, especially of ammonia and an amine.

Abstract: Imides reduce odors. Imides are especially efficient at reducing the odors of odoriferous an amine or ammonia. The imides may be incorporated in pads which are the recipients of odoriferous waste materials, dispersed in holding tanks or lagoons or dispersed over human and animal wastes. Polysuccinimide, copolymers of polysuccinimide, polyglutarimide and mixtures thereof are especially useful for the reduction of odors, especially of ammonia and an amine.